Isnain, Sitti Farrah S.
HRN: 28-53-97 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/19/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/19/2026
07/25/2026
IV
90mg
Q8
Intraabdominal Infection
Checking Final Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes